These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9796985)

  • 1. Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.
    Kinders R; Jones T; Root R; Bruce C; Murchison H; Corey M; Williams L; Enfield D; Hass GM
    Clin Cancer Res; 1998 Oct; 4(10):2511-20. PubMed ID: 9796985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor H as a marker for detection of bladder cancer.
    Cheng ZZ; Corey MJ; Pärepalo M; Majno S; Hellwage J; Zipfel PF; Kinders RJ; Raitanen M; Meri S; Jokiranta TS
    Clin Chem; 2005 May; 51(5):856-63. PubMed ID: 15774575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human complement factor H related protein test for monitoring bladder cancer.
    Raitanen MP; Marttila T; Nurmi M; Ala-Opas M; Nieminen P; Aine R; Tammela TL;
    J Urol; 2001 Feb; 165(2):374-7. PubMed ID: 11176376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder.
    Irani J; Desgrandchamps F; Millet C; Toubert ME; Bon D; Aubert J; Le Duc A
    Eur Urol; 1999 Feb; 35(2):89-92. PubMed ID: 9933800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.
    Babjuk M; Kostírová M; Mudra K; Pecher S; Smolová H; Pecen L; Ibrahim Z; Dvorácek J; Jarolím L; Novák J; Zima T
    Eur Urol; 2002 Jan; 41(1):34-9. PubMed ID: 11999463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative detection of human complement factor H-related protein in transitional cell carcinoma of the urinary bladder.
    Heicappell R; Wettig IC; Schostak M; Müller M; Steiner U; Sauter T; Miller K
    Eur Urol; 1999 Jan; 35(1):81-7. PubMed ID: 9933798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer.
    Raitanen MP; Marttila T; Kaasinen E; Rintala E; Aine R; Tammela TL
    J Urol; 2000 Jun; 163(6):1689-92. PubMed ID: 10799161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
    Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
    BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative determination of urinary human complement factor H-related protein (hcfHrp) in patients with bladder cancer, healthy controls, and patients with benign urologic disease.
    Heicappell R; Müller M; Fimmers R; Miller K
    Urol Int; 2000; 65(4):181-4. PubMed ID: 11112865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer.
    Thomas L; Leyh H; Marberger M; Bombardieri E; Bassi P; Pagano F; Pansadoro V; Sternberg CN; Boccon-Gibod L; Ravery V; Le Guludec D; Meulemans A; Conort P; Ishak L
    Clin Chem; 1999 Apr; 45(4):472-7. PubMed ID: 10102906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?
    Mahnert B; Tauber S; Kriegmair M; Nagel D; Holdenrieder S; Hofmann K; Reiter W; Schmeller N; Stieber P
    Clin Chem Lab Med; 2003 Jan; 41(1):104-10. PubMed ID: 12636058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of monoclonal antibodies against human bladder cancer cells and application to immunohistochemical analysis of bladder cancer].
    Saiki S; Meguro N; Morita T; Tomooka Y; Maeda O; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Nihon Hinyokika Gakkai Zasshi; 1990 Oct; 81(10):1537-42. PubMed ID: 2273706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder.
    Mian C; Lodde M; Haitel A; Egarter Vigl E; Marberger M; Pycha A
    Urology; 2000 Aug; 56(2):228-31. PubMed ID: 10925083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the BTA stat test kit for bladder cancer screening.
    Nasuti JF; Gomella LG; Ismial M; Bibbo M
    Diagn Cytopathol; 1999 Jul; 21(1):27-9. PubMed ID: 10405804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test.
    Raitanen MP; Hellström P; Marttila T; Korhonen H; Talja M; Ervasti J; Tammela TL;
    Eur Urol; 2001 Oct; 40(4):422-6. PubMed ID: 11713397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine.
    Chopin DK; Caruelle JP; Colombel M; Palcy S; Ravery V; Caruelle D; Abbou CC; Barritault D
    J Urol; 1993 Oct; 150(4):1126-30. PubMed ID: 7690426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors.
    Giannopoulos A; Manousakas T; Mitropoulos D; Botsoli-Stergiou E; Constantinides C; Giannopoulou M; Choremi-Papadopoulou H
    Urology; 2000 Jun; 55(6):871-5. PubMed ID: 10840098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.